Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project
暂无分享,去创建一个
Maria Dusinska | Michael Riediker | Richard D Handy | Lucienne Juillerat-Jeanneret | Andrew R Collins | L. Juillerat-Jeanneret | A. Collins | M. Dusinska | R. Handy | M. Riediker | L. Fjellsbø | Lise Marie Fjellsbø
[1] Maria Dusinska,et al. The importance of life cycle concepts for the development of safe nanoproducts. , 2010, Toxicology.
[2] Sabina Passamonti,et al. Hemolytic effects of water-soluble fullerene derivatives. , 2004, Journal of medicinal chemistry.
[3] Shu F. Situ,et al. Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy. , 2013, Nanoscale.
[4] Mauro Ferrari,et al. An integrated approach for the rational design of nanovectors for biomedical imaging and therapy. , 2010, Advances in genetics.
[5] Vladimir Murashov,et al. Adverse Effects of Engineered Nanomaterials Exposure, Toxicology, and Impact on Human Health , 2013 .
[6] S. Klaine,et al. Paradigms to assess the environmental impact of manufactured nanomaterials , 2012, Environmental toxicology and chemistry.
[7] B. Demirdjian,et al. Probing functional groups at the gas-aerosol interface using heterogeneous titration reactions: a tool for predicting aerosol health effects? , 2010, Chemphyschem : a European journal of chemical physics and physical chemistry.
[8] M. Kruszewski,et al. Time‐dependent biodistribution and excretion of silver nanoparticles in male Wistar rats , 2012, Journal of applied toxicology : JAT.
[9] Andrzej S Pitek,et al. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. , 2012, ACS nano.
[10] Yiwei Teow,et al. Health Impact and Safety of Engineered Nanomaterials , 2011 .
[11] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[12] Anjali U. Patel,et al. Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan , 2011, Journal of advanced pharmaceutical technology & research.
[13] Xiang Wang,et al. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. , 2013, Accounts of chemical research.
[14] V. Preedy. Nanomedicine in Health and Disease , 2011 .
[15] Albert Duschl,et al. Time evolution of the nanoparticle protein corona. , 2010, ACS nano.
[16] Mauro Ferrari,et al. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. , 2011, Accounts of chemical research.
[17] Michael Riediker,et al. Therapeutic nanoparticles in clinics and under clinical evaluation. , 2013, Nanomedicine.
[18] Georg Neubauer,et al. Possible effects of electromagnetic fields (EMF) on human health--opinion of the scientific committee on emerging and newly identified health risks (SCENIHR). , 2008, Toxicology.
[19] David Y Lai,et al. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[20] Maria Dusinska,et al. Testing strategies for the safety of nanoparticles used in medical applications. , 2009, Nanomedicine.
[21] L. Juillerat-Jeanneret. Critical Analysis of Cancer Therapy using Nanomaterials , 2007 .
[22] Hans-Jürgen Dr. Klüppel,et al. The Revision of ISO Standards 14040-3 - ISO 14040: Environmental management Life cycle assessment Principles and framework - ISO 14044: Environmental management Life cycle assessment Requirements and guidelines , 2005 .
[23] W. Kreyling,et al. Translocation of Inhaled Nanoparticles , 2011 .
[24] Qasim Chaudhry,et al. A complementary definition of nanomaterial , 2010 .
[25] Houria Boulaiz,et al. Nanomedicine: Application Areas and Development Prospects , 2011, International journal of molecular sciences.
[26] Richard D Handy,et al. Manufactured nanoparticles: their uptake and effects on fish—a mechanistic analysis , 2008, Ecotoxicology.
[27] P. Borm,et al. Nanoparticles in drug delivery and environmental exposure: same size, same risks? , 2006, Nanomedicine.
[28] L. Juillerat-Jeanneret,et al. Toxicity data of therapeutic nanoparticles in patent documents , 2013 .
[29] M. Pautler,et al. Nanomedicine: promises and challenges for the future of public health , 2010, International journal of nanomedicine.
[30] Christoph Alexiou,et al. Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health , 2012 .
[31] David E Newby,et al. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? , 2006, American journal of respiratory and critical care medicine.
[32] J. Pluta,et al. In vivo study on the biodistribution of silica particles in the bodies of rats. , 2012, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[33] M. Dobrovolskaia,et al. Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.
[34] M. Saunders,et al. Critical Evaluation of Toxicity Tests , 2012 .
[35] Sven Ove Hansson,et al. Assessment factors for extrapolation from short-time to chronic exposure--are the REACH guidelines adequate? , 2009, Toxicology letters.
[36] Iseult Lynch,et al. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices , 2011, Nanotoxicology.
[37] Iseult Lynch,et al. The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.
[38] Mark Crane,et al. The ecotoxicology and chemistry of manufactured nanoparticles , 2008, Ecotoxicology.
[39] P. Boor,et al. Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats , 2014, Nanotoxicology.
[40] A. Peters,et al. Particulate Matter Air Pollution and Cardiovascular Disease: An Update to the Scientific Statement From the American Heart Association , 2010, Circulation.
[41] A. Park,et al. CENTER FOR DRUG EVALUATION AND RESEARCH , 2009 .
[42] Steffen Foss Hansen,et al. Environmental challenges for nanomedicine. , 2008, Nanomedicine.
[43] P. Borm,et al. Testing Strategies to Establish the Safety of Nanomaterials: Conclusions of an ECETOC Workshop , 2007, Inhalation toxicology.
[44] Maria Dusinska,et al. Toxicological aspects for nanomaterial in humans. , 2013, Methods in molecular biology.
[45] Stefan Bechtold,et al. Directive 2001/29/EC of the European Parliament and of the Council of 22 May 2001 on the Harmonisation of Certain Aspects of Copyright and Related Rights in the Information Society , 2016 .
[46] Saber M Hussain,et al. Toxicity testing of nanomaterials. , 2012, Advances in experimental medicine and biology.
[47] Maria Dusinska,et al. Health effects of selected nanoparticles in vivo: liver function and hepatotoxicity following intravenous injection of titanium dioxide and Na-oleate-coated iron oxide nanoparticles in rodents , 2015, Nanotoxicology.
[48] Fabian Kiessling,et al. Theranostic nanomedicine. , 2020, Accounts of chemical research.
[49] Y. K. Agrawal,et al. Nanosuspension: An approach to enhance solubility of drugs , 2011, Journal of advanced pharmaceutical technology & research.
[50] M A Vandelli,et al. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[51] Ali Khademhosseini,et al. Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[52] Maria Dusinska,et al. Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. , 2010, The Science of the total environment.
[53] Marco Vighi,et al. SCCP (Scientific Committee on Consumer Products) / SCHER (Scientific Committee on Health& Environment Risks) / SCENIHR (Scientific Committee on Emerging and Newly- Identified Health Risks) opinion on: Risk assessment methodologies and approaches for genotoxic and carcinogenic substances , 2009 .
[54] W. Kreyling,et al. Translocation of Inhaled Ultrafine Particles to the Brain , 2004, Inhalation toxicology.
[55] Manuela Semmler-Behnke,et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.